ArticleFrontiers in oncology2023

Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations.

Benedikt Färber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.